News
Important Only
AbbVie To Acquire Capstan Therapeutics, Further Strengthening Commitment To Transforming Patient Care In Immunology
June 30 (Reuters) - Abbvie Inc ABBV.N:ABBVIE TO ACQUIRE CAPSTAN THERAPEUTICS, FURTHER STRENGTHENING COMMITMENT TO TRANSFORMING PATIENT CARE IN IMMUNOLOGYABBVIE INC - TO PAY UP TO $2.1 BILLION IN CASH FOR CAPSTANReuters
Mon, Jun 30
Senate Republicans try to get Trump's tax cuts over the line, setting aside cost concerns
Democrats criticize bill for potential Medicaid, SNAP cutsSenate Republicans face internal divisions over bill's debt impactRand Paul opposes bill due to $5 trillion borrowing limit increaseBy Richard Cowan and Bo Erickson WASHINGTON, June 30 (Reuters) - U.S. Senate Republicans on Monday will...Reuters
Mon, Jun 30
935 people killed in Israeli strikes on Iran, official says
DUBAI, June 30 (Reuters) - Some 935 people were killed in Iran during the 12-day air war with Israel, based on the latest forensic data, a spokesperson for the Iranian judiciary said on Monday, according to state media.Among the dead were 38 children and 132 women, the spokesperson, Asghar Jahangir,...Reuters
Mon, Jun 30
Intensity Therapeutics Inc Int230-6 Achieved 100% Complete Response Rate In Preclinical Models Of Malignant Peripheral Nerve Sheath Tumors
Intensity Therapeutics Inc INTS.O:INTENSITY THERAPEUTICS INC: INT230-6 ACHIEVED 100% COMPLETE RESPONSE RATE IN PRECLINICAL MODELS OF MALIGNANT PERIPHERAL NERVE SHEATH TUMORSReuters
Mon, Jun 30
Cirsa Says Price Of Its IPO At 15 Eur/Shr
June 30 (Reuters) - Cirsa Enterprises, S.A.U:PRICE OF ITS INITIAL PUBLIC OFFERING OF SHARES AT 15 EUROS PER SHARESHARES WILL BE LISTED ON STOCK EXCHANGES OF BARCELONA, MADRID, BILBAO AND VALENCIA, AND WILL BEGIN TRADING UNDER TICKER SYMBOL "CIRSA"Source text: https://tinyurl.com/54nnmrs3Reuters
Mon, Jun 30
Tokyo Lifestyle Co., Ltd.’S Hong Kong Subsidiary Signs Hk$100 Million Strategic Revolving Loan Facility To Fuel Global Expansion
Tokyo Lifestyle Co Ltd TKLF.O:TOKYO LIFESTYLE CO., LTD.’S HONG KONG SUBSIDIARY SIGNS HK$100 MILLION STRATEGIC REVOLVING LOAN FACILITY TO FUEL GLOBAL EXPANSIONReuters
Mon, Jun 30
Imunon Submits Plan In Consultation With Exchange To Ensure Compliance With Nasdaq's Listing Requirement, Anticipates Additional Compliance Period
Imunon Inc IMNN.O:IMUNON SUBMITS PLAN IN CONSULTATION WITH EXCHANGE TO ENSURE COMPLIANCE WITH NASDAQ'S LISTING REQUIREMENT, ANTICIPATES ADDITIONAL COMPLIANCE PERIODReuters
Mon, Jun 30
Corbus Pharmaceuticals Initiates Multiple Ascending Dose Portion Of Phase 1 Study Of Highly Peripherally Restricted Cb1 Inverse Agonist Crb-913 For The Treatment Of Obesity
Corbus Pharmaceuticals Holdings Inc CRBP.O:CORBUS PHARMACEUTICALS INITIATES MULTIPLE ASCENDING DOSE PORTION OF PHASE 1 STUDY OF HIGHLY PERIPHERALLY RESTRICTED CB1 INVERSE AGONIST CRB-913 FOR THE TREATMENT OF OBESITYReuters
Mon, Jun 30
